Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
(Sharecast News) - AstraZeneca said on Friday that positive high-level results from the 'HIMALAYA' phase 3 trial showed a single, high priming dose of tremelimumab added to 'Imfinzi', or durvalumab. demonstrated a statistically-significant and clinically meaningful overall survival (OS) benefit for carcinomas associated with liver cancer.
Read more
ABUJA, Oct 14 (Reuters) - Nigeria has received 501,600 doses of AstraZeneca's COVID-19 vaccine from the French government through the COVAX vaccine-sharing facility, a senior health official said on Thursday.Faisal Shuaib, head of the National Pri...
Read more
European drug watchdog reviews AstraZeneca anti-Covid cocktail
Read more* Treatment is first COVID preventative shot other than vaccines* Drug, Evusheld, shown to save lives and prevent severe disease* EMA gives no timeline for possible approval (Adds detail)Oct 14 (Reuters) - Europe's drug regulator said on Thursday ...
Read more* STOXX 600 on course for weekly gains* Chip stocks boosted by TSMC results* Publicis up on outlook hike (New throughout, updates prices, market activity and comments to close)By Sruthi Shankar and Susan MathewOct 14 (Reuters) - European stocks ros...
Read more(Repeats to fix story ID; no changes to text)GENEVA, Oct 13 (Reuters) - The World Health Organization (WHO) said on Wednesday that its newly formed advisory group on dangerous pathogens may be "our last chance" to determine the origins of the SARS...
Read moreGENEVA, Oct 13 (Reuters) - The World Health Organization (WHO) said on Wednesday that its newly formed advisory group on dangerous pathogens may be "our last chance" to determine the origins of the SARS-CoV-2 virus and called for cooperation from ...
Read moreLONDON MARKET CLOSE: Stocks mixed as oil majors, miners lift FTSE 100
Read moreOct 11 (Reuters) - GlaxoSmithKline on Monday laid out plans for a new, 120 million pound ($164 million) headquarters for its soon-to-be-independent consumer healthcare business and also said its remaining pharmaceuticals and vaccines staff will ...
Read moreLONDON BROKER RATINGS: Berenberg starts Dunelm and Wickes at Buy
Read moreTOP NEWS: AstraZeneca gets positive results from Covid-19 drug trial
Read more* Shortly after infection, drug cuts risk of deterioration* Astra sees shot's main use in preventative setting* Faces competition from other antibodies, Merck tablet (Adds quotes from media call)By Ludwig Burger, Yadarisa Shabong and Sachin Ravikuma...
Read more(Adds detail on rival treatments)By Yadarisa Shabong and Sachin RavikumarOct 11 (Reuters) - AstraZeneca's experimental COVID-19 drug has helped cut the risk of severe disease or death in a late-stage study, the British drugmaker said on Monday, a ...
Read moreLONDON MARKET PRE-OPEN: ASOS CEO to leave; warns on profit amid costs
Read more(Sharecast News) - AstraZeneca said its antibody cocktail to combat Covid-19 had achieved a "statistically significant reduction" in the risk of developing the virus or death in a phase 3 trial.
Read more
Last checked at